Program Planning and Evaluation provides a structured framework for assessing our current status, identifying opportunities and formulating approaches for implementing the mission of the Vanderbilt-Ingram Cancer Center (VICC); VICC employs strategic planning, external evaluation, and internal evaluation to inform and support its decision-making processes. The significant progress of VICC, described throughout this renewal application, continues to provide evidence demonstrating VICC's effective use of both internal and external planning and evaluation processes. A new strategic plan was initiated at the last competing renewal with a focus on expansion of research programs through continued recruitment of talented investigators that joined the VICC membership and collectively advanced the following areas: 1) implementation of innovative approaches in basic, translational and clinical investigation; 2) responsive cancer epidemiology and population- based research initiatives; 3) genotype-driven clinical trials and informatics; 4) cancer drug discovery; 5) further integration of animal and human imaging; and 6) hematological malignances. Fifty-nine (59) faculty recruitments and $149M of investments were made during the current project period across the continuum of cancer research areas. External evaluation was provided by two national groups that advise VICC senior leadership and membership on opportunities, development of programs and the merit of research accomplishments: the External Scientific Advisory Board and the Board of Overseers. Finally, there are several internal mechanisms that provide comprehensive internal planning and evaluation within VICC; these include the executive committee, research program leaders committee, shared resources oversight group, and others. Together, these external and internal evaluation groups provide advice to the Director, who has ultimate responsibility and authority for setting priorities for the development of new research programs and shared resources; recruiting and retaining scientists and scientific leaders; selecting programs, projects and individuals to receive seed grant funding; determining use of VICC space and resources; and organizing the Center as a whole to promote scientific interactions and enhance productivity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-23
Application #
9553500
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
23
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Piñeros, Marion; Frech, Silvina; Frazier, Lindsay et al. (2018) Advancing Reliable Data for Cancer Control in the Central America Four Region. J Glob Oncol :1-11

Showing the most recent 10 out of 2462 publications